Vigonvita nominates new board slate as first-term directors near end of mandate

PUBT·04/30/2026 12:27:46

Listen to the news

Vigonvita Life Sciences flagged a board refresh ahead of expiry of first board term on March 26, 2026.
Chairman and CEO Tian Guanghui was nominated to continue as executive director; he joined Vigonvita in 2013 and previously worked at API-focused drug developer Topharman Shanghai.
Deputy general manager Hu Tianwen was nominated to continue as executive director; he previously served as a researcher at Topharman Shanghai from 2016 to 2022.
Non-executive director Liu Haoxuan was nominated to continue; he is general manager of Yunnan Suwangrun Biopharmaceutical since 2021.
Board slate also includes independent non-executive directors Ju Dianwen, Cao Xinwen, Xu Hongxi; Ju is a Fudan University pharmacy researcher, Cao is chief accountant at Shanghai Minxing Accounting Firm, Xu is a professor at Shanghai University of Traditional Chinese Medicine.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vigonvita Life Sciences Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260430-12140616), on April 30, 2026, and is solely responsible for the information contained therein.

FAQ

Fee Schedule Open Account Deposit & Withdrawal Trading

Terms & Conditions

Client Agreement Privacy Policy Data Disclaimer Security Tips

About Webull

About us Webull Promotions Contact information Announcements

Contact Number :+852 3852 8500

Monday 7:00 AM - Saturday 9:00 AM (HKT)

Service Email :service@webull.hk

Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)

Business Cooperation :marketinghk@webull.hk

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.

Language

English